Cargando…
Lurasidone for the treatment of schizophrenia in adult and paediatric populations
Schizophrenia is a common debilitating disorder characterized by significant impairments in how reality is perceived, combined with behavioural changes. In this review, we describe the lurasidone development programme for adult and paediatric patients. Both the pharmacokinetic and pharmacodynamic ch...
Autores principales: | Guilera, Teresa, Chart Pascual, Juan Pablo, Blasco, Maria del Carmen, Calvo Estopiñán, Pilar, Piernas González, Rubén Asensio, Ramírez Martínez, Isabel, Rodríguez Moyano, Cristóbal, Prieto Pérez, Rita, Gabarda-Inat, Irene, Prados-Ojeda, Juan L, Diaz-Marsà, Marina, Martín-Carrasco, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914098/ https://www.ncbi.nlm.nih.gov/pubmed/36793449 http://dx.doi.org/10.7573/dic.2022-10-1 |
Ejemplares similares
-
Clinical characteristics of lurasidone-treated patients in Spain using Natural Language Processing – A real-world data study with Electronic Health Records
por: De La Pinta, C., et al.
Publicado: (2022) -
Clinical potential of lurasidone in the management of schizophrenia
por: Samalin, Ludovic, et al.
Publicado: (2011) -
Critical appraisal of lurasidone in the management of schizophrenia
por: Caccia, Silvio, et al.
Publicado: (2012) -
The clinical utility of lurasidone in schizophrenia: patient considerations
por: Harvey, Philip D
Publicado: (2015) -
Identification of clinical phenotypes in schizophrenia: the role of lurasidone
por: Riva, Marco Andrea, et al.
Publicado: (2021)